Illimis Therapeutics logo

Illimis Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
0
Total Funding
$64.3M
Investors
0 investors across all rounds

No investor data available

Explore More Data
Detailed analysis for Illimis Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Illimis Therapeutics Leadership & Investors

Illimis Therapeutics is led by a team of experienced leaders.

Investment Opportunity

Accredited investors can access Illimis Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.